期刊文献+

兔抗人CXCR3-B分子N端多肽多克隆抗体的制备与初步应用 被引量:6

Generation and preliminary application of rabbit anti-human polyclonal antibodies against NH_2-terminal peptides of CXCR3-B
下载PDF
导出
摘要 目的: 获得兔抗人CXCR3-B分子N端第1~19、第17~35及第33~51个氨基酸多肽的多克隆抗体, 并对多克隆抗体进行初步鉴定和应用.方法: 应用Fmoc法化学合成CXCR3-B分子N端第1~19、第17~35及第33~51个氨基酸多肽, 经C18的RP-HPLC纯化后, 通过高碘酸钠法将纯化的CXCR3-B分子的多肽与KLH交联;皮下注射抗原免疫日本大耳白兔, 加强免疫得到抗血清, 应用蛋白G纯化获得多克隆抗体.对纯化的抗体进行ELISA、免疫印迹、免疫组化等初步鉴定和应用.结果: 分别化学合成CXCR3-B分子N端第1~19、第17~35及第33~51个氨基酸多肽, 纯化后多肽纯度分别为98%、 88.54%及80%, 达到免疫用抗原标准.多肽与KLH交联, 用于免疫动物.经纯化后的抗体效价分别为1∶ 32 000(0.1 mg/L), 1∶ 4 000(3 mg/L)和1∶ 1 000(10 mg/L).3种多肽的抗体可特异识别胎心组织中相对分子质量(Mr)约为50的CXCR3-B分子, 相应抗原定位于3种多肽的抗体可特异识别胎心组织中的血管内皮细胞.结论: 所制备的多克隆抗体可应用于ELISA、免疫印迹和免疫组化等实验, 为确定CXCR3-B分子的组织及细胞分布和定位、寻找CXCR3-B相互作用的分子提供了有力的工具. AIM: To generate and identify the rabbit polyclonal antibodies against NH2-terminal peptides of CXCR3-B. METHODS: Three peptides (aa. 1 to 19, aa. 17 to 35, and aa. 33 to 51 ) of human CXCR3-B NH2-terminus were synthesized by using standard Fmoc. The synthesized peptides were purified by reversed phase high-performance liquid chromatography (RP-HPLC), and cross-linked with keyhole limpet hemocyanin (KLH) by sodium metaperio- date. Rabbits were immunized with conjugated pepUdes for 3 times (400 μg/rabbit). The polyclonal antibodies were pudried by Protein G from the collected antiserum. RESULTS: NH2-terminal peptides of human CXCR3-B with the purity of 98%, 88.54%, and 80%, respectively, were prepared. The titers of purified polyclonal antibodies were 1 : 32 000 (0. 1 mg/L), 1:4000 (3 mg/L), and 1:1 000 (10 mg/L), respectively. Western blot results showed that the antibodies could recognize the protein with molecular weight of .50 000 in the total lysates of human fetal heart, whereas the anti- bodies against the peptides of No. ! - 19 amino acids could also recognize an additional protein (40 000), The antigens recognized by the antibodies were localized in the vascular endothelial cells of human fetal heart tissues, CONCLUSION: The polyclonal antibodies against NH2-terminal pep- tides generated and identified in the present work are specific to CXCR3-B protein and therefore can be useful tools for the functional study of human CXCR3-B.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2006年第2期223-226,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家重点基础研究发展规划(973)资助项目(No.2002-CB513106 2001CB510200) 国家科技攻关计划资助项目(No.2004BA711A20)
关键词 CXCR3-B 多克隆抗体 多肽抗原 CXCR3-B polyclonal antibody poly peptideantigen
  • 相关文献

参考文献7

  • 1Hansell P,Maione TE,Borgstrom P,et al.Selective binding of platelet factor 4 to regions of active angiogenesis in vivo[J].Am J Physiol,1995,269(3Pt2):H829-836.
  • 2Bergers G,Benjamin LE.Tumorigenesis and the angiogenic switch[J].Nat Rev Cancer,2003,3(6):401-410.
  • 3Perollet C,Han ZC,Savona C,et al.Platelet factor 4 modulates fibroblast growth factor 2 (FGF2) activity and inhibits FGF-2 dimerization[J].Blood,1998,91(9):3289-3299.
  • 4Gengrinovitch S,Greenberg SM,Cohen T,et al.Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms[J].J Bio Chem,1995,270(25):15059-15065.
  • 5Lasagni L,Francalanci M,Annunziato F,et al.An alternatively spliced variant of CXCR3 mediates the inhibition of endothelia cell growth induced by IP-10,Mig,and I-TAC,and acts as functional receptor for platelet factor 4[J].J Exp Med,2003,197(11):1537-1549.
  • 6Xanthou G,Williams TJ,Pease JE,et al.Molecular characterization of the chemokine receptor CXCR3:evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation[J].Eur J Immunol,2003,33(10):2927-2936.
  • 7Clark-Lewis I,Mattioli I,Gong JH,et al.Structure-function relationship between the human chemokine receptor CXCR3 and its ligands[J].J Bio Chem,2003,278(1):289-295.

同被引文献41

  • 1江平,侯艳宁,陈兴.大鼠P450侧链裂解酶抗原决定簇多参数预测及合成[J].免疫学杂志,2005,21(6):489-492. 被引量:2
  • 2马群风,江红,刘锟,朱捷,郑晓飞.兔抗MDA-7/IL-24多克隆抗体的制备和特异性鉴定[J].细胞与分子免疫学杂志,2006,22(3):380-381. 被引量:6
  • 3杜雪梅,唐丽,柳晓兰,陈勇,高建恩,贺福初,孙启鸿.抗人LSECtin单克隆抗体的制备与初步鉴定[J].细胞与分子免疫学杂志,2006,22(4):517-520. 被引量:5
  • 4哈洛E,莱恩D.抗体技术实验指南[M].北京:科学出版社,2002.9.
  • 5Lee JI,Chaves G,Amico JA,et al.Application of semisimuhaneous midazolam administration for hepatic and intestinal cytoehrome P450 3A phenotyping[J].Phamacogene Genom,2002,72(6):718-728.
  • 6Beatty JD,Beatty BG,Wlanos WG.Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay[J].Immunol Methods,1987,100(1-2):173-179.
  • 7Cho BH,Park BL,Kim LH,et al.Highly polymorphic human CYP4A11 gene[J].J Hum Genet,2005,50(5):259-263.
  • 8Gainer JV,Bellamine A,Dawson EP,et al.Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension[J].Circulation,2005,111(1):63-69.
  • 9Gonzalez MC,Marteau C,Frauchi J,et al.Cytochrome P450 4A11 expression in human keratinocytes:effects of ultraviolet irradiation[J].Br J Dermatol,2001,145(5):749-757.
  • 10Beatty JD,Beatty BG,Wlanos WG,et al.Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay[J].J Immunol Methods,1987,100(1-2):173-179.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部